Introduction: The Evolving Landscape of Novel Psychoactive Substances (NPS) The emergence of novel psychoactive substances (NPS) has presented significant challenges to forensic chemists, clinical toxicologists, public health researchers, and regulatory bodies worldwide. Unlike traditional drugs of abuse, NPS are often synthesized in clandestine laboratories with slight modifications to molecular structures to circumvent existing legal frameworks. […]
Gastrointestinal, Metabolic, and Autoimmune Drug Research: A Preclinical Overview of Mesalamine, Budesonide, Dexilant, Nexium, Domperidone, Rifaximin, Creon, Stelara, and Wegovy
Introduction: The Frontier of Drug Discovery in GI, Metabolic, and Autoimmune Disorders The landscape of gastroenterology, metabolic health, and autoimmunity is undergoing a seismic shift. For researchers and procurement specialists, understanding the bridge between preclinical mechanisms and clinical application is vital. Drugs like Mesalamine and Budesonide have long been the standard for inflammatory bowel conditions, while next-generation biologics like Stelara and metabolic modulators […]